Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cells (Q40408257)

20 September 2017

Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cells (English)

1 reference

20 September 2017

hepatocellular carcinoma

1 reference

Kerstin Herzer

1

1 reference

20 September 2017

Tom M Ganten

2

1 reference

20 September 2017

Henning Schulze-Bergkamen

3

1 reference

20 September 2017

Anne Grosse-Wilde

4

1 reference

20 September 2017

Ronald Koschny

5

1 reference

20 September 2017

Peter H Krammer

6

1 reference

20 September 2017

Henning Walczak

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

20 September 2017

1 reference

20 September 2017

42

1 reference

20 September 2017

183-192

1 reference

20 September 2017

1

1 reference

Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice

20 September 2017

1 reference

Role of transforming growth factor beta in human disease

21 January 2018

1 reference

7 January 2021

Apoptosis and the liver

1 reference

7 January 2021

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions

1 reference

7 January 2021

Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.

1 reference

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

7 January 2021

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

7 January 2021

Characterization of two receptors for TRAIL

1 reference

7 January 2021

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

1 reference

7 January 2021

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

7 January 2021

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

7 January 2021

Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes

1 reference

7 January 2021

Tumor necrosis factor receptor and Fas signaling mechanisms.

1 reference

7 January 2021

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

1 reference

7 January 2021

Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL

1 reference

7 January 2021

Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells.

1 reference

7 January 2021

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

1 reference

7 January 2021

Primary human hepatocytes--a valuable tool for investigation of apoptosis and hepatitis B virus infection

1 reference

7 January 2021

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

1 reference

7 January 2021

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

7 January 2021

Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity

1 reference

7 January 2021

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

1 reference

7 January 2021

Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.

1 reference

7 January 2021

Standardization of the Human in vitro Cell-mediated Lympholysis Technique

1 reference

7 January 2021

Apoptosis in liver disease

1 reference

7 January 2021

Growth modulatory effects of a liver-derived growth inhibitor, transforming growth factor beta 1, and recombinant tumor necrosis factor alpha, in normal and neoplastic cells

1 reference

7 January 2021

Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade

1 reference

7 January 2021

TGFbeta signaling pathways and human diseases

1 reference

7 January 2021

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis

1 reference

7 January 2021

Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation

1 reference

7 January 2021

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB

1 reference

7 January 2021

Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors

1 reference

7 January 2021

Is TRAIL hepatotoxic?

1 reference

7 January 2021

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

7 January 2021

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

7 January 2021

TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice

1 reference

7 January 2021

TGF-beta signaling in tumor suppression and cancer progression

1 reference

7 January 2021

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20757

1 reference

20 September 2017

1 reference